Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer

Overview of attention for article published in Journal of Ovarian Research, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 tweeters

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 13 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 4 tweets from 4 users, with an upper bound of 1,266 followers.

Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer. https://t.co/LCecQS1FeU

02 May 2019

Reply Retweet Favourite

Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer. https://t.co/EmkimOeg82

02 May 2019

Reply Retweet Favourite

Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer. https://t.co/kOn89AIwOR

02 May 2019

Reply Retweet Favourite

Our sister journal, The Journal of Ovarian Research is publishing important research on women's reproductive health. Their latest explore using fusing gene therapy in ovarian cancer treatment! Check it out: https://t.co/9CTWxuL3WA https://t.co/NbX712m59k

01 May 2019

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.